The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer Inc

This publication has 8 references indexed in Scilit: